4
Changes in Ownership
Cytek Biosciences, Inc. Filed Acc 0001209191-22-058474
Chief Technology Officer sold 20,000 shares at $14.66 ($293,200)
- Chief Technology Officer gave up 772 shares (to pay taxes)
- Chief Technology Officer acquired 1,981 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Yan Ming Chief Technology Officer | 2022-11-18 | Option exercise | +1,981 | 8,007,605 | D | ||
| Yan Ming Chief Technology Officer | 2022-11-18 | Shares withheld for taxes | −772 | $14.75 | $11,387 | 8,006,833 | D |
| Yan Ming Chief Technology Officer | 2022-11-21 | Sale | −20,000 | $14.66 | $293,200 | 7,986,833 | D |
| Derivatives | |||||||
| Yan Ming Chief Technology Officer | 2022-11-18 | Option exercise · Restricted Stock Units | −1,981 | 25,104 | D | ||
| Open-market sales · 20,000 sh · avg $14.66 · $293,200 | |||||||
Loading xslF345X03/doc4.xml…